Breath Biopsies 2019: A Revolutionary Approach for Noninvasive Diagnosis – ResearchAndMarkets.com – Business Wire

Posted: Published on November 24th, 2019

This post was added by Alex Diaz-Granados

DUBLIN--(BUSINESS WIRE)--The "Breath Biopsies: A Revolutionary Approach for Noninvasive Diagnosis" report has been added to ResearchAndMarkets.com's offering.

Report Includes:

Summary

In the future, a variety of conditions may be diagnosed with a simple breath test. Researchers are looking beyond blood tests and solid/liquid biopsies to find other sources of information to diagnose disease. Every time an individual breathes, thousands of volatile organic compounds (VOCs) and volatile fatty acids (VFAs), the breakdown products of lipids and proteins,1 are released into the breath. These novel biomarkers are by-products of metabolism, and can provide a snapshot of an individual's health.

Key Topics Covered:

Chapter 1 Monitoring Volatile Organic Compounds

Chapter 2 Value Proposition of Breath Testing

Chapter 3 Applications in Diagnostics

Chapter 4 Companies and Technologies for Which to Watch Out

Chapter 5 References

For more information about this report visit https://www.researchandmarkets.com/r/vhlmxq

See the original post here:
Breath Biopsies 2019: A Revolutionary Approach for Noninvasive Diagnosis - ResearchAndMarkets.com - Business Wire

Related Posts
This entry was posted in MS Treatment. Bookmark the permalink.

Comments are closed.